BACKGROUND: China's HIV epidemic commenced in its agrarian provinces through contaminated commercial plasma donation centers and is now becoming a public health concern nationwide. Little is known of the psychiatric and substance use disorder characteristics of this population, or their impact on everyday function, employment, and life quality. METHODS: HIV-infected (HIV+) former plasma donors (N=203) and HIV-negative (HIV-) donor controls (N=198) completed the World Mental Health Survey Composite International Diagnostic Interview to determine lifetime major depressive disorder (MDD), substance use disorders, and suicidality. Current mood and suicidality were assessed with the Beck Depression Inventory-II. Everyday function was measured by an Activity of Daily Living questionnaire; life quality was evaluated by the Medical Outcomes Study-HIV. RESULTS: HIV+ participants had known their infected status for 2 years on average. Most were taking antiretroviral treatment and had frank AIDS. Rates of current MDD were similar across groups (1-2%), but HIV+ had a higher frequency of lifetime MDD (14% vs. 5%, p<.05). Its onset preceded date of known infection in one-third of cases. Alcoholism was the only substance use disorder detected; HIV+ had a higher proportion of lifetime substance use diagnoses (14% vs. 6%, p<.05). Depression and AIDS independently predicted worse daily functioning and life quality, and unemployment. LIMITATIONS: The epicenter of China HIV has moved into urban injection drug users, limiting the representativeness of this sample. CONCLUSIONS: High rates of MDD and its impact suggest that in China, as elsewhere, comprehensive care requires detection and treatment of mood disorder. Published by Elsevier B.V.
BACKGROUND:China's HIV epidemic commenced in its agrarian provinces through contaminated commercial plasma donation centers and is now becoming a public health concern nationwide. Little is known of the psychiatric and substance use disorder characteristics of this population, or their impact on everyday function, employment, and life quality. METHODS:HIV-infected (HIV+) former plasma donors (N=203) and HIV-negative (HIV-) donor controls (N=198) completed the World Mental Health Survey Composite International Diagnostic Interview to determine lifetime major depressive disorder (MDD), substance use disorders, and suicidality. Current mood and suicidality were assessed with the Beck Depression Inventory-II. Everyday function was measured by an Activity of Daily Living questionnaire; life quality was evaluated by the Medical Outcomes Study-HIV. RESULTS:HIV+ participants had known their infected status for 2 years on average. Most were taking antiretroviral treatment and had frank AIDS. Rates of current MDD were similar across groups (1-2%), but HIV+ had a higher frequency of lifetime MDD (14% vs. 5%, p<.05). Its onset preceded date of known infection in one-third of cases. Alcoholism was the only substance use disorder detected; HIV+ had a higher proportion of lifetime substance use diagnoses (14% vs. 6%, p<.05). Depression and AIDS independently predicted worse daily functioning and life quality, and unemployment. LIMITATIONS: The epicenter of China HIV has moved into urban injection drug users, limiting the representativeness of this sample. CONCLUSIONS: High rates of MDD and its impact suggest that in China, as elsewhere, comprehensive care requires detection and treatment of mood disorder. Published by Elsevier B.V.
Authors: E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro Journal: Arch Gen Psychiatry Date: 2001-08
Authors: Robert K Heaton; Lucette A Cysique; Hua Jin; Chuan Shi; Xin Yu; Scott Letendre; Donald R Franklin; Christopher Ake; Ofilio Vigil; J Hampton Atkinson; Thomas D Marcotte; Igor Grant; Zunyou Wu Journal: J Neurovirol Date: 2008-11 Impact factor: 2.643
Authors: Robert K Heaton; Thomas D Marcotte; Monica Rivera Mindt; Joseph Sadek; David J Moore; Heather Bentley; J Allen McCutchan; Carla Reicks; Igor Grant Journal: J Int Neuropsychol Soc Date: 2004-05 Impact factor: 2.892
Authors: Rujvi Kamat; Erin Morgan; Thomas D Marcotte; Jayraan Badiee; Ingrid Maich; Mariana Cherner; Sergio de Almeida; Ana Paula de Pereira; Clea Elisa Ribeiro; Francisco Barbosa; J Hamp Atkinson; Ronald Ellis Journal: J Affect Disord Date: 2012-12-11 Impact factor: 4.839
Authors: Georgette D Kanmogne; Fang Qiu; Félicien E Ntone; Julius Y Fonsah; Dora M Njamnshi; Callixte T Kuate; Roland F Doh; Anne M Kengne; Claude T Tagny; Emilienne Nchindap; Léopoldine Kenmogne; Dora Mbanya; Mariana Cherner; Robert K Heaton; Alfred K Njamnshi Journal: PLoS One Date: 2017-02-23 Impact factor: 3.240